Home Cart Sign in  
Chemical Structure| 81131-70-6 Chemical Structure| 81131-70-6

Structure of Pravastatin Sodium
CAS No.: 81131-70-6

Chemical Structure| 81131-70-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pravastatin Sodium is a competitive HMG-CoA reductase inhibitor with IC50 value of 5.6 μM.

Synonyms: CS-514 sodium; Pravastatin (sodium salt)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pravastatin Sodium

CAS No. :81131-70-6
Formula : C23H35NaO7
M.W : 446.51
SMILES Code : O=C([O-])C[C@H](O)C[C@H](O)CC[C@H]1[C@@H](C)C=CC2=C[C@@H](O)C[C@H](OC([C@@H](C)CC)=O)[C@]12[H].[Na+]
Synonyms :
CS-514 sodium; Pravastatin (sodium salt)
MDL No. :MFCD00887601
InChI Key :VWBQYTRBTXKKOG-IYNICTALSA-M
Pubchem ID :16759173

Safety of Pravastatin Sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H351-H361
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Acta2R149C/+ SMCs 250 nM 72 hours decreased expression of Atf4 and Klf4 and KLF4 activity and prevented augmented phenotypic modulation PMC10393072
iPSC-ECs 1 μM 24 hours Pravastatin significantly increased cell migration, proliferation, and the ability to form cord-like structures, while significantly reducing apoptosis. PMC4381134

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice Acta2R149C/+Apoe−/− mice drinking water 5 mg/kg every other day for 28 days lowered circulating serum lipid levels to a similar extent in both genotypes and prevented the increased plaque burden in Acta2R149C/+Apoe?/? male mice when compared to similarly treated Apoe?/? mice PMC10393072
Mice Hindlimb ischemia model Intraperitoneal injection 4 mg/kg Immediately after SCI and every other day until the experiments were terminated Pravastatin significantly increased hindlimb reperfusion, but this effect was blocked by the NO synthase inhibitor L-NAME. PMC4381134
Mice Slco1b2−/− mice and NASH model Intravenous injection 4 mg/kg bw Every other day for 38 days To investigate the synergistic effect of Oatp1b2 genetic loss and NASH on pravastatin disposition. Results showed that the combination of Oatp1b2 genetic loss and NASH caused a significant increase in pravastatin plasma and muscle concentrations. PMC4065643
Swiss mice Amyloidosis induction model Intraperitoneal injection 4 mg/kg bw Every other day for 38 days To study the effect of Pravastatin on amyloidogenesis, results showed that high-dose Pravastatin may have a mild amyloid-protective effect in the short term PMC1754113
Mice DSS-induced colitis model Oral 30 mg/kg once daily for 4 days To investigate the impact of colitis on the in vivo clearance of Pravastatin, results showed no significant effect of colitis on Pravastatin clearance. PMC6976992

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00982189 HIV Infection ... More >> Cardiovascular Disease Risk Less << Not Applicable Completed - United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Less <<
NCT01857921 Coronary Artery Not Applicable Unknown October 2016 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Myeong Ki Hong, MD, PhD    82-2-2228-8460    mkhong61@yuhs.ac Less <<
NCT00697203 Dyslipidemia Phase 2 Completed - -
NCT00982189 - Completed - -
NCT03131973 Rheumatoid Arthritis Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT00384618 Chronic Kidney Disease Phase 4 Terminated - Netherlands ... More >> VU University Medical Center Amsterdam, North Holland, Netherlands, 1007 MB Less <<
NCT02841774 HIV Infection ... More >> Coronary Heart Disease Less << Phase 2 Recruiting March 2019 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Matthew Feinstein, MD       matthewjfeinstein@northwestern.edu    Principal Investigator: Matthew Feinstein, MD Less <<
NCT01011127 - Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT01557075 Drug-eluting Stent (DES) Phase 4 Unknown August 2015 Korea, Republic of ... More >> Hong Myeong-Ki Recruiting Seoul, Korea, Republic of Contact: Myeong-Ki Hong, MD.PhD    +82 2 2228 8458    mkhong61@yuhs.ac    Contact: Byeong-Keuk Kim, MD.PhD    +82 2 2228 8465    kimbk@yuhs.ac    Principal Investigator: Myeong-Ki Hong, MD.PhD Less <<
NCT00701285 Chronic Heart Failure Phase 4 Completed - Korea, Republic of ... More >> SEOUL St. Mary's Hospital Seoul, Seocho-Ku, Korea, Republic of, 137-040 Less <<
NCT00546559 - Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405760 Less <<
NCT00214604 Hyperlipoproteinemia Type III Phase 3 Completed - Norway ... More >> Research Site Oslo, Norway South Africa Research Site Cape Town, South Africa Less <<
NCT02045966 Hepatitis C Phase 1 Completed - -
NCT00221104 Ischemic Stroke Phase 3 Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT03073018 Microalbuminuria ... More >> Cardiovascular Diseases Renal Disease Less << Phase 3 Completed - -
NCT00221104 - Completed - -
NCT02871687 Healthy Subjects Phase 1 Recruiting December 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital- 221 Longwood Avenue Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Jonathan Williams, MD          Sub-Investigator: Tina Gupta, MD Less <<
NCT02155530 Coronary Artery Disease Not Applicable Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00245388 Dyslipidemia Phase 2 Phase 3 Completed - -
NCT01357486 Hepatocellular Carcinoma ... More >> CHILD B Less << Phase 2 Completed - France ... More >> CH d'Abbeville Abbeville, France, 80142 CH Pays d'Aix Aix-en-provence, France, 13616 CH d'Auxerre Auxerre, France, 89011 CH de la Côte Basque Bayonne, France, 64109 AP-HP- Hôpital Jean-Verdier Bondy, France, 93143 CHU de Bordeaux Bordeaux, France, 33075 CH Duchenne Boulogne Sur Mer, France, 62321 CH de Béziers Béziers, France, 34525 AP-HP Hôpital Henri Mondor Creteil, France, 94010 CHU Le Bocage Dijon, France, 21079 CH Départemental Vendée La Roche-sur-yon, France, 85925 CH Le Mans Le Mans, France, 72037 CH de Bretagne Sud Lorient, France, 56100 Hôpital privé Jean Mermoz Lyon, France, 69008 AP-HM Hôpital de la Timone Marseille, France, 13385 CH de Meaux Meaux, France, 77104 CH Mont de Marsan Mont-de-marsan, France, 40024 CHU de Nancy Hôpital Brabois Nancy, France, 54511 CHU de Nantes Hôpital de l'Hotel Dieu Nantes, France, 44093 CHU Nîmes Nimes, France, 30029 CHR d'Orléans - Hôpital La Source Orleans, France, 45067 Groupe Hospitalier Paris Saint Joseph Paris, France, 75014 CH Perpignan Perpignan, France, 66046 CHU de Bordeaux, Hôpital du Haut Lévèque Pessac, France, 33604 CH de la Région d'Annecy Pringy, France, 74374 Centre Eugène Marquis Rennes, France, 35042 Clinique Mathilde Rouen, France, 76000 Clinique Armoricaine de Radiologie Saint Brieuc, France, 22015 CH Saint-Malo Saint Malo, France, 35400 Centre René Gauducheau CLCC Nantes Atlantique Saint-herblain, France, 44805 CH Gaston Ramon Sens, France, 89100 Centre Régional de Lutte contre le Cancer Centre Paul Strauss Strasbourg, France, 67065 Hôpitaux Universitaires de Strasbourg Hôpital civil Strasbourg, France, 67091 Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre Strasbourg, France, 67098 CHRU de Tours Tours, France, 37044 Less <<
NCT00456365 Polycystic Kidney, Autosomal D... More >>ominant Less << Phase 3 Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Denver, Colorado, United States, 80262 Less <<
NCT00303277 Alzheimer's Disease ... More >> Aging Less << Phase 4 Completed - United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT00005117 Heart Diseases Not Applicable Unknown - United States, Colorado ... More >> 4200 E. 9th Avenue, Box B133 Denver, Colorado, United States, 80262 Less <<
NCT00380939 Coronary Arteriosclerosis Phase 4 Completed - -
NCT01816997 Diabetes Phase 4 Recruiting December 2022 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    886-2-28757515       Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT02456844 Rheumatoid Arthritis Phase 1 Completed - -
NCT00456365 - Completed - -
NCT00549926 Coronary Disease ... More >> Hypercholesterolemia Less << Phase 4 Completed - Japan ... More >> Yokohama City University Medical Center Yokohama, Japan Less <<
NCT00166036 Diabetes Mellitus ... More >> Metabolic Syndrome X Hypercholesterolemia Less << Phase 2 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT02266485 Healthy Phase 1 Completed - -
NCT00166036 - Completed - -
NCT03273413 ADPKD Autosom... More >>al Dominant Polycystic Kidney Less << Phase 4 Recruiting December 2021 United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Campus Recruiting Denver, Colorado, United States, 80045 Contact: Nina Z Bispham, MS    303-724-1692    nina.bispham@ucdenver.edu    Contact: Beverly Farmer, RN    303-724-7790    beverly.farmer@ucdenver.edu    Principal Investigator: Michel B Chonchol, MD Less <<
NCT02484261 Leukemia Phase 1 Active, not recruiting August 2020 United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT02431013 Dyslipidemias ... More >> Peripheral Artery Disease Less << Phase 1 Unknown - Korea, Republic of ... More >> Ajou University Medical Center Recruiting Suwon, Gyeonggi, Korea, Republic of, 443-380 Contact: Doo-Yeoun Cho, MD    +82-31-219-4271    dooycho@ajou.ac.kr    Principal Investigator: Doo-Yeoun Cho, MD Less <<
NCT00405717 Ischemic Heart Disease ... More >> Acute Coronary Syndromes Less << Phase 4 Completed - China, Liaoning ... More >> Northern Hospital Shenyang, Liaoning, China Less <<
NCT00433498 Lung Cancer Phase 3 Completed - -
NCT00631189 Type IIa and IIb Hypercholeste... More >>rolaemia Less << Phase 4 Completed - -
NCT00107523 Leukemia Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00631189 - Completed - -
NCT00200655 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 3 Completed - France ... More >> Nantes University Hospital Nantes, France, 44093 Less <<
NCT01004237 Hypertension ... More >>High Cholesterol Less << Phase 4 Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT01301066 Dyslipidemia Phase 4 Completed - -
NCT00654537 Hypercholesterolemia Phase 3 Completed - -
NCT00362206 Hyperlipidemia Phase 3 Completed - -
NCT01301066 - Completed - -
NCT00639223 Hypercholesterolemia ... More >> Statin-Associated Myopathy Less << Phase 2 Completed - United States, Pennsylvania ... More >> Chestnut Hill Hospital Philadelphia, Pennsylvania, United States, 19118 Less <<
NCT01515813 HIV-1 Infection Phase 2 Withdrawn(On 05/08/12, team wo... More >>rking on revising protocol and re-open study under version 2.0) Less << December 2014 United States, California ... More >> UCLA CARE Center CRS (601) Los Angeles, California, United States, 90095 Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States, 90502 United States, Missouri Washington University CRS (2101) St. Louis, Missouri, United States, 63110 United States, North Carolina Unc Aids Crs (3201) Chapel Hill, North Carolina, United States, 27514 Duke University Medical Center Adult CRS (1601) Durham, North Carolina, United States, 27710 Regional Center for Infectious Disease, Wendover Medical Center CRS (3203) Greensboro, North Carolina, United States, 27401 United States, Ohio The Ohio State University AIDS CRS (2301) Colombus, Ohio, United States, 43210 United States, Tennessee Vanderbilt Therapeutics CRS (3652) Nashville, Tennessee, United States, 37232 United States, Texas Houston AIDS Research Team CRS (31473) Houston, Texas, United States, 77030 Less <<
NCT00147797 - Completed - France ... More >> Department of Pharmacology and INSERM U652, Hôpital Européen Georges Pompidou Paris, France, 75015 Less <<
NCT00639223 - Completed - -
NCT00257686 Hypercholesterolemia or Combin... More >>ed Dyslipidemia Less << Phase 3 Completed - -
NCT01845428 Nephrotic Syndrome ... More >> Hyperlipidemia Less << Phase 1 Completed - United States, North Carolina ... More >> Unc Kidney Center Chapel Hill, North Carolina, United States, 27599-7155 Less <<
NCT00843661 HIV Hyperlipi... More >>demia HIV Infections Less << Phase 4 Unknown July 2012 Italy ... More >> Ospedale di Circolo and Fondazione Macchi Recruiting Varese, Italy, 21100 Contact: Anna Maria Grandi, MD    +390332278403    amgrandi@libero.it Less <<
NCT00177580 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - United States, Pennsylvania ... More >> Western Psychiatric Institute & Clinic Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00529178 Hypercholesterolemia Phase 4 Completed - -
NCT00227500 HIV Infections ... More >> Lipid Metabolism Glucose Metabolism Metabolic Abnormality Lipodystrophy Cardiovascular Disease Less << Phase 4 Completed - Australia, New South Wales ... More >> St. Vincents Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT00840177 Leukemia Phase 2 Active, not recruiting July 2019 -
NCT01903694 Child-Pugh A Hepatocellular Ca... More >>rcinoma Less << Phase 3 Completed - France ... More >> CHU de Dijon Dijon, France, 21079 Less <<
NCT00257686 - Completed - -
NCT00117494 Hyperlipidemia ... More >> HIV Infections Less << Phase 4 Completed - France ... More >> service de Médecine Interne Hopital Hotel Dieu Paris, France, 75004 Less <<
NCT01602913 - Completed - -
NCT00221754 HIV Infection ... More >> Hypercholesterolemia Less << Phase 2 Completed - France ... More >> Hôpital Saint André, Service de médecine interne et maladies infectieuses Bordeaux, France, 33000 Less <<
NCT00688896 Type II Hyperlipidemia Phase 2 Completed - Netherlands ... More >> Amsterdam, Netherlands Less <<
NCT02360826 Drug Distribution Phase 1 Completed - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00006412 HIV Infections ... More >> Lipodystrophy Less << Phase 3 Completed - -
NCT00688922 Acute Myocardial Infarction Phase 4 Unknown June 2011 Japan ... More >> Kansai Rosai Hospital Recruiting Amagasaki, Hyogo, Japan Contact: Shinsuke Nanto, MD/PhD    81-6-6416-1221       Principal Investigator: Shinnsuke Nanto, MD/PhD          Higashi-Osaka City General Hospital Recruiting Higashi-Osaka, Osaka, Japan Contact: Yoshiyuki Kijima, MD/PhD          Principal Investigator: Yoshiyuki Kijima, MD/PhD          Kawachi General Hospital Recruiting Higashi-Osaka, Osaka, Japan Contact: Masayoshi Mishima, MD/PhD          Principal Investigator: Masayoshi Mishima, MD/PhD          Osaka Minami Medical Center, National Hospital Organization Recruiting Kawachinagano, Osaka, Japan Contact: Tatsuya Sasaki, MD/PhD          Principal Investigator: Tatsuya Sasaki, MD/PhD          Osaka Rosai Hospital Recruiting Sakai, Osaka, Japan Contact: Masami Nishino, MD/PhD          Principal Investigator: Masami Nishino, MD/PhD          Osaka University Hospital Recruiting Suita, Osaka, Japan, 565-0871 Contact: Yasuhiko Sakata, MD/PhD    81-6-6879-6612    sakatayk@medone.med.osaka-u.ac.jp    Principal Investigator: Yasuhiko Sakata, MD/PhD          Osaka General Medical Center Not yet recruiting Osaka, Japan Contact: Masatake Fukunami, MD/PhD          Principal Investigator: Masatake Fukunami, MD/PhD          Osaka Police Hospital Recruiting Osaka, Japan Contact: Yasunori Ueda, MD/PhD    81-6-6771-6051       Principal Investigator: Yasunori Ueda, MD/PhD          Sakurabashi Watanabe Hospital Not yet recruiting Osaka, Japan Contact: Hiroshi Ito, MD/PhD          Contact: Motoo Date, MD/PhD          Principal Investigator: Hiroshi Ito, MD/PhD          Sub-Investigator: Motoo Date, MD/PhD Less <<
NCT01256476 Primary Dyslipidemia ... More >> Mixed Dyslipidemia Less << Phase 4 Completed - -
NCT01256476 - Completed - -
NCT01958489 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less <<
NCT02547402 Acute Kidney Injury Phase 1 Completed - United States, Michigan ... More >> Jasper Clinical Research & Development, Inc. Kalamazoo, Michigan, United States, 49007 Less <<
NCT00916747 Progeria Phase 2 Enrolling by invitation July 2020 United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT00599625 Crohn's Disease Not Applicable Unknown December 2011 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Brian Behm, MD    434-924-2959    bwb2c@virginia.edu    Contact: Meredith Gross    434-924-2753    mpg8b@virginia.edu    Principal Investigator: Brian Behm, MD Less <<
NCT03456102 Tuberculosis Phase 2 Not yet recruiting September 1, 2021 -
NCT01057654 Hypercholesterolemia ... More >> Hyperlipoproteinemia Less << Phase 3 Completed - Germany ... More >> Dept. of Clinical Pharmacology, University of Bonn Bonn, Germany, 53105 Less <<
NCT01872845 Coronary Artery Occlusive Dise... More >>ase Less << Not Applicable Unknown May 2018 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: MyeongKi Hong, MD, PhD    82-2-2228-8460    mkhong61@yuhs.ac Less <<
NCT00755352 Hypercholesterolemia Phase 4 Completed - United States, California ... More >> Los Angeles, California, United States United States, Colorado Castle Rock, Colorado, United States United States, Florida Jacksonville, Florida, United States Pembroke Pines, Florida, United States St. Petersburg, Florida, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Kentucky Louisville, Kentucky, United States United States, New York Rochester, New York, United States United States, Ohio Cincinnati, Ohio, United States Cleveland, Ohio, United States United States, Tennessee Bartlett, Tennessee, United States United States, Virginia Norfolk, Virginia, United States Richmond, Virginia, United States United States, Washington Seattle, Washington, United States Less <<
NCT00834847 Healthy Phase 1 Completed - Canada, Ontario ... More >> Pharma Medica Research Inc. Toronto, Ontario, Canada, M1R 5A3 Less <<
NCT01958489 - Completed - -
NCT01075555 Liver Cancer Phase 3 Completed - France ... More >> Hopital Du Bocage Dijon, France, 21000 Less <<
NCT00382460 Actue Coronary Syndromes Phase 4 Completed - -
NCT02166593 Combined Dyslipidemia Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01325818 Coronary Disease ... More >> Hypercholesterolemia Less << Phase 4 Unknown February 2016 Japan ... More >> Yokohama City University Medical Center Recruiting Yokohama, Japan Contact: Kenichiro Saka    81-45-261-5656    Ken_saka@yokohama-cu.ac.jp    Principal Investigator: Kenichiro Saka Less <<
NCT00702130 Ventilator Associated Pneumoni... More >>a Less << Early Phase 1 Completed - Greece ... More >> General Hospital Larissa Larissa, Thessalia, Greece, 41221 Zakynthinos E. Dir-University Hospital Larisa Mezourlo / Larissa, Greece, 41110 Less <<
NCT00834379 Healthy Phase 1 Completed - Canada, Ontario ... More >> Pharma Medica Research Inc. Toronto, Ontario, Canada, M1R 5A3 Less <<
NCT00731016 Hutchinson-Gilford Progeria Sy... More >>ndrome Less << Phase 2 Completed - France ... More >> Laboratoire de Génétique Moléculaire - Hopital de la Timone Marseille, France, 13385 Less <<
NCT03219372 Hepatocellular Carcinoma ... More >> Liver Cirrhoses Less << Phase 2 Recruiting June 1, 2022 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Shehnaz Hussain, PhD    310-423-6401    Shehnaz.Hussain@cshs.org    Contact: Sandra Contreras    424-315-2216    sandra.contreras@cshs.org    Sub-Investigator: Walid Ayoub, MD          Sub-Investigator: Marc Goodman, PhD          Sub-Investigator: Mazen Noureddin, MD          Sub-Investigator: Laura Kulik, MD          Sub-Investigator: Vatche Agopian, MD          Sub-Investigator: Richard Finn, MD          Sub-Investigator: David Lu, MD          Sub-Investigator: Otoniel Martinez-Maza, PhD Less <<
NCT01038154 Esophageal Cancer ... More >> Stomach Cancer Less << Phase 4 Unknown November 2012 Spain ... More >> Department Gastroenterology. Hospital Donostia Recruiting San Sebastián, Guipúzcoa, Spain, 20014 Contact: Luis Bujanda, Prof.    34-943007173    luis.bujanda@osakidetza.net Less <<
NCT00630734 HIV Infections ... More >> Hyperlipidemia Less << Phase 4 Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT01268202 Fibrosis Phase 2 Unknown July 2016 France ... More >> Centre Val d'Aurelle Not yet recruiting Montpellier, France, 34298 Contact: David AZRIA, MD          Principal Investigator: David AZRIA, MD          Hôpital Européen Georges Pompidou Not yet recruiting Paris, France, 75015 Contact: Philippe GIRAUD, MD          Principal Investigator: Philippe GIRAUD, MD          Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Céline BOURGIER, MD, PhD    33 1 42 11 49 31    bourgier@igr.fr    Contact: Anne AUPERIN, MD, PhD    33 1 42 11 54 99    auperin@igr.fr    Principal Investigator: Céline BOURGIER, MD, PhD Less <<
NCT00665717 HIV Infections Phase 1 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands Less <<
NCT02754739 Diabetes Mellitus ... More >> Prediabetic State Less << Phase 4 Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT00630734 - Completed - -
NCT02079974 Endometriosis Not Applicable Withdrawn - Canada, Ontario ... More >> Mount Sinai Hospital, University of Toronto Toronto, Ontario, Canada, M5G 1X5 Less <<
NCT00650221 Therapeutic Equivalency Phase 1 Completed - Canada, Ontario ... More >> Biovail Contract Research Toronto, Ontario, Canada, M1L 4S4 Less <<
NCT02992548 Chronic Kidney Disease Phase 4 Active, not recruiting August 2018 Korea, Republic of ... More >> Dong-A University Busan, Korea, Republic of, 602715 Inje University, Pusan Paik Hospital Busan, Korea, Republic of Less <<
NCT01418729 Advanced Hepatocarcinoma Phase 2 Completed - Spain ... More >> Hospital Donostia, Instituto Biodonostia San Sebastian, Gipuzkoa, Spain, 20014 Less <<
NCT00459745 Combined Hyperlipidemia Phase 3 Completed - -
NCT01254461 Drug Interaction Phase 1 Completed - Sweden ... More >> Research Site Uppsala, Sweden Less <<
NCT00879034 - Completed - -
NCT00879034 Progeria Hutc... More >>hinson-Gilford Syndrome Less << Phase 2 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT02621957 Breast Cancer Phase 1 Completed - United States, Florida ... More >> Daytona Beach, Florida, United States, 32117 Less <<
NCT01497483 Healthy Phase 1 Completed - United States, California ... More >> San Francisco General Hosptail San Francisco, California, United States, 94110 Less <<
NCT01342887 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01342887 - Terminated - -
NCT00571194 End Stage Renal Disease Phase 1 Terminated - United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 Less <<
NCT00571194 - Terminated - -
NCT01831232 - Completed - -
NCT00830258 Healthy Phase 1 Completed - Canada, Ontario ... More >> Pharma Medica Research Inc. Toronto, Ontario, Canada, M1R 5A3 Less <<
NCT01082588 - Completed - -
NCT00829309 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT01831232 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Refractory Anemia With Excess Blasts Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00829309 - Completed - -
NCT00830258 - Completed - -
NCT01146093 Healthy PHASE1 COMPLETED 2025-03-03 -
NCT01146106 Healthy PHASE1 COMPLETED 2025-12-02 -
NCT00648544 Therapeutic Equivalency Phase 1 Completed - Canada, Ontario ... More >> Biovail Contract Reseach Toronto, Ontario, Canada, M1L 4S4 Less <<
NCT03648970 Pre-Eclampsia Phase 2 Recruiting December 1, 2020 Indonesia ... More >> Sanglah General Hospital Not yet recruiting Denpasar, Bali, Indonesia Contact: Ryan Saktika Mulyana, MD, OBGYN       ryanmul83@gmail.com    Principal Investigator: Ryan Saktika Mulyana, MD, OBGYN          Sub-Investigator: Evert Pangkahila, MD, OBGYN          Dr. Moewardi Hospital Not yet recruiting Surakarta, Central Java, Indonesia, 57126 Contact: Muhammad Adrianes Bachnas, MD, OBGYN    +628122692928    bachnasadri@gmail.com    Principal Investigator: Muhammad Adrianes Bachnas, MD, OBGYN          Sub-Investigator: Eric Edwin, MD, OBGYN          Ramelan Naval Hospital Not yet recruiting Surabaya, East Java, Indonesia, 60244 Contact: Agung Sunarko Putra, MD, OBGYN    +62811257852    dr.agung_sp@yahoo.com    Principal Investigator: Agung Sunarko Putra, MD, OBGYN          Sub-Investigator: Frans OH Prasetyadi, MD, OBGYN          Dr. Soetomo Hospital Recruiting Surabaya, East Java, Indonesia, 60285 Contact: Muhammad Ilham Aldika Akbar, MD, OBGYN    +6281703270900    dokter_aldi@yahoo.com    Adam Malik General Hospital Not yet recruiting Medan, North Sumatra, Indonesia Contact: Dudy Aldiansyah       dudya141277@gmail.com    Principal Investigator: Dudy Aldiansyah, MD, OBGYN          Sub-Investigator: Makmur Sitepu, MD, OBGYN          Dr. Wahidin Sudirohusodo General Hospital Not yet recruiting Makasar, South Sulawesi, Indonesia Contact: Deviana Soraya Riu, MD, OBGYN       virayariu@gmail.com    Principal Investigator: Deviana Soraya Riu, MD, OBGYN          Sub-Investigator: Ellen Theresia Wawengkang, MD, OBGYN          Hasan Sadikin General Hospital Recruiting Bandung, West Java, Indonesia Contact: Muhammad Alamsyah Azis, MD, Obgyn       alamsyahaziz9119@gmail.com    Principal Investigator: Muhammad Alamsyah Azis, MD, Obgyn          Sub-Investigator: Johanes Cornelius Mose, MD, OBGYN Less <<
NCT01082588 Schizophrenia ... More >> Schizoaffective Disorders Schizophreniform Disorders Less << Phase 4 Completed - United States, Massachusetts ... More >> Freedom Trail Clinic Boston, Massachusetts, United States, 02114 Less <<
NCT01717586 Preeclampsia Phase 1 Recruiting April 2019 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Katherine Wisner, MD    312-926-2323    Katherine.Wisner@northwestern.edu    Contact: Minaz Kolia, MD    312-695-7190    minaz.kolia@northwestern.edu    United States, Pennsylvania University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Steve Caritis, MD    412-641-4874    scaritis@mail.magee.edu    Contact: Dawn Fischer, RN    412-641-5194    dfischer@mail.magee.edu    Principal Investigator: Steve Caritis, MD          United States, Texas University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Maged Costantine, MD    409-772-1571    mmcostan@utmb.edu    Contact: Holly West, PA-C    409-747-8234    hawest@utmb.edu Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.20mL

2.24mL

1.12mL

22.40mL

4.48mL

2.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories